Page last updated: 2024-11-06

dibenzocycloheptadiene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Dibenzocycloheptadiene is a polycyclic aromatic hydrocarbon that has been studied for its potential use in the synthesis of pharmaceuticals and other organic molecules. It is a relatively stable compound that can be synthesized through a variety of methods, including the Diels-Alder reaction and the Friedel-Crafts acylation. Dibenzocycloheptadiene has also been shown to exhibit biological activity, including anti-inflammatory and anti-cancer effects. However, its potential toxicity and environmental impact have also been investigated, leading to ongoing research to explore its potential applications and safety considerations.'

10,11-dihydro-5H-dibenzo(a,d)cycloheptene: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID70029
CHEMBL ID564180
MeSH IDM0040900

Synonyms (29)

Synonym
5h-dibenzo[a,d]cycloheptene, 10,11-dihydro-
10,11-dihydro-5h-dibenzo(a,d)cycloheptene
6,11-dihydro-5h-dibenzo[[?],[?]][7]annulene
dibenzosuberane
833-48-7
nsc-86156
nsc86156
dibenzosuberane, 98%
inchi=1/c15h14/c1-3-7-14-11-15-8-4-2-6-13(15)10-9-12(14)5-1/h1-8h,9-11h
10,11-dihydro-5h-dibenzo[a,d][7]annulene
CHEMBL564180
FT-0666413
CCG-40519
dibenzocycloheptadiene
nsc 86156
unii-gu7kln5ed5
gu7kln5ed5 ,
einecs 212-630-5
10,11-dihydro-5h-dibenzo[a,d]cycloheptene
dibenzo[a,d][1,4]cycloheptadiene
DTXSID10232254
tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,11,13-hexaene
AKOS027320569
tricyclo[9.4.0.0?,?]pentadeca-1(11),3,5,7,12,14-hexaene
tricyclo[9.4.0.0(3),?]pentadeca-1(11),3,5,7,12,14-hexaene
AS-65655
10,11-dihydro-5h-dibenzo[a,d]cycloheptene (dibenzosuberane)
10,11-dihydro-5h-dibenzo[a,d]cycloheptene; dibenzosuberane
Q256369
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID420787Antagonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as inhibition of serotonin-induced inward Na+ current at >= 10 uM2009European journal of medicinal chemistry, Jun, Volume: 44, Issue:6
Molecular properties of psychopharmacological drugs determining non-competitive inhibition of 5-HT3A receptors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (37.50)18.7374
1990's2 (25.00)18.2507
2000's2 (25.00)29.6817
2010's1 (12.50)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 17.19

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index17.19 (24.57)
Research Supply Index2.30 (2.92)
Research Growth Index4.31 (4.65)
Search Engine Demand Index10.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (17.19)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]